Rare diseases
Investigational molecules
Locations
Back to Hungary22 clinical trials in Farkasgyepu, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials exploring immunotherapy combinations for advanced non-small cell lung cancer (NSCLC), focusing on treatment options for patients with various stages of the disease.
Research aims to improve survival rates and treatment outcomes through targeted immunological approaches.
Studies evaluating targeted therapies for specific mutations in non-small cell lung cancer, including HER2 and KRAS G12C mutations.
Investigations focus on personalized treatment strategies for different NSCLC subtypes.
Clinical trials examining new therapeutic options for small cell lung cancer, including novel drug combinations and comparative effectiveness studies.
Research focuses on improving treatment options for patients with relapsed SCLC.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
